COVID-19 Data Platform

Q4 2021
  • Implementation challenges
    • EOSC interoperability
  • Result description

    COVID-19 Data Platform is an infrastructure that provides access to open literature and data on both the virus and the disease. It enhances researchers in their efforts towards critical information resources. The European COVID-19 Data Platform consists of three components: the COVID-19 Data Portal, the SARS-Cov-2 Data Hubs, and the Federated EGA (European Genome Phenome Archive).

    Problem addressed

    Data across different data types is integrated and linked to promote FAIR and open sharing and usage for the benefit of the global scientific community. Long term infrastructure is provided for SARS-CoV-2 and COVID-19 data that will remain publicly available and re-usable. The infrastructure built can be repurposed to be used for future pandemics as well.

    Who can use the result

    Any citizens, researchers, health care professionals and policy makers on thematic, national and European level.

    Timeline

    The BY-COVID project is one of the Horizon Europe projects that supports the operation of the European COVID-19 Data Platform. BY-COVID runs till 30 September 2024. Platform launched Q2, 2020 HORIZON-HLTH-2023-DISEASE-03-07: Relationship between infections and non- communicable diseases. Applicants are encouraged to link to the COVID-19 Data Platform. In July 2023, EMBL’s European Bioinformatics Institute (EMBL-EBI) has launched the Pathogens Portal – an online platform that enables researchers, clinicians, and policymakers to access the most comprehensive collection of biomolecular data about pathogens. The Pathogens Portal is built on the same framework as the European COVID-19 Data Portal and is supported by European Union funding through the RECODID (Horizon 2020 no. 825746), VEO (Horizon 2020 no. 874735) and BY-COVID (Horizon Europe no. 101046203) projects.

    How to use the result

    Type of result